MyOme
Developer of a genetic testing technology designed to provide comprehensive health insights through whole genome sequencing. The company's platform offers detailed reports on disease risk and medicati...
Valuation
$186.5M
Market implied
Share Price
N/A
Total Raised
$99.9M
Last Round
N/A